Treatment of Pleural Mesothelioma: ASCO Guideline Update
Hedy L. Kindler(University of Chicago), Raffit Hassan(National Cancer Institute), Alexandra Lebensohn(National Institutes of Health), Lyudmila Bazhenova(Memorial Sloan Kettering Cancer Center), Ibiayi Dagogo‐Jack(Massachusetts General Hospital), Marc de Perrot(University Health Network), Valerie W. Rusch(Memorial Sloan Kettering Cancer Center), David L. Graham(Levine Cancer Institute), Patrick M. Forde(Sidney Kimmel Comprehensive Cancer Center), Jennifer L. Sauter(Memorial Sloan Kettering Cancer Center), Azam Ghafoor(National Cancer Institute), Quincy S. Chu, Nofisat Ismaila(American Society of Clinical Oncology), Aliya N. Husain(University of Chicago), Darren S. Bryan(University of Chicago), John Cho(University Health Network), Ola Khorshid(Cairo University), Jane E. Churpek(University of Wisconsin–Madison), Penelope A. Bradbury(University Health Network), Michael W. Drazer(Susan Thompson Buffett Foundation)
Cited by 55
Related Papers
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
|Molecular Cancer Therapeutics|2017|2.4k
Maintenance Olaparib for Germline <i>BRCA</i> -Mutated Metastatic Pancreatic Cancer
|New England Journal of Medicine|2019|2.2k
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
|New England Journal of Medicine|2018|2.1k
Genome-wide cell-free DNA fragmentation in patients with cancer
|Nature|2019|1.5k